image du produit

The Journal of Prevention of Alzheimer's Disease

Sommario

Vol 11 - N° 4 - août 2024

P. 801-1179

© SERDI Publisher. Published by Elsevier Masson SAS.

Editorial
- ·Introduction to the Special Issue on the A4 Study
  
  Pagina :801
  
  Paul Aisen, R. Sperling
Original Research
- ·Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies
  
  Pagina :802-813
  
  Reisa A. Sperling, M.C. Donohue, R.A. Rissman, K.A. Johnson, D.M. Rentz, J.D. Grill, J.L. Heidebrink, C. Jenkins, G. Jimenez-Maggiora, O. Langford, A. Liu, R. Raman, R. Yaari, K.C. Holdridge, J.R. Sims, P.S. Aisen, A4 and LEARN Study Teams
  Riassunto Riassunto Mappa Mappa
- ·Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study
  
  Pagina :814-822
  
  Dorene M. Rentz, P.B. Rosenberg, R.A. Sperling, M.C. Donohue, R. Raman, A. Liu, P.S. Aisen, A4 study team
  Riassunto Riassunto Mappa Mappa
- ·Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease
  
  Pagina :823-830
  
  Robert A. Rissman, M.C. Donohue, O. Langford, R. Raman, S. Abdel-Latif, R. Yaari, K.C. Holdridge, J.R. Sims, D. Molina-Henry, G. Jimenez-Maggiora, K.A. Johnson, P.S. Aisen, R.A. Sperling, A4 and LEARN Study teams
  Riassunto Riassunto Mappa Mappa
- ·Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4
  
  Pagina :831-837
  
  Doris Molina-Henry, O. Langford, M.C. Donohue, R. Raman, P. Aisen, K.A. Johnson, R.A. Rissman, R. Sperling, A4 & LEARN Study Teams
  Riassunto Riassunto Mappa Mappa
- ·Longitudinal Trajectories of the Cognitive Function Index in the A4 Study
  
  Pagina :838-845
  
  Rebecca E. Amariglio, J.D. Grill, D.M. Rentz, G.A. Marshall, M.C. Donohue, A. Liu, P.S. Aisen, R.A. Sperling, A4 Study team
  Riassunto Riassunto Mappa Mappa
- ·Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study
  
  Pagina :846-856
  
  Kathryn V. Papp, P. Maruff, D.M. Rentz, M.C. Donohue, A. Liu, P.S. Aisen, R.A. Sperling, A4 Study Team
  Riassunto Riassunto Mappa Mappa
- ·Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial
  
  Pagina :857-868
  
  Roy Yaari, K.C. Holdridge, M. Mancini, M.S. Rafii, M. Case, C. Battioui, J.R. Sims, P.S. Aisen, R.A. Sperling, A4 Study Team
  Riassunto Riassunto Mappa Mappa
- ·Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer’s Disease
  
  Pagina :869-873
  
  Zahra Shirzadi, A.P. Schultz, M. Properzi, R. Yaari, W.-Y. W. Yau, A.M. Brickman, M.S. Rafii, M.C. Donohue, K. Ernstrom, S. Wang, C.R. Jack, S.M. Greenberg, R. Raman, P. Aisen, R.A. Sperling, J.P. Chhatwal, A4 Study teams
  Riassunto Riassunto Mappa Mappa
- ·Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial
  
  Pagina :874-880
  
  Rema Raman, K. Hussen, M.C. Donohue, K. Ernstrom, K.C. Holdridge, O. Langford, D.P. Molina-Henry, A.L. Pierce, J.R. Sims, A. Smith, R. Yaari, P.S. Aisen, R. Sperling, J.D. Grill, A4 Study Team
  Riassunto Riassunto Mappa Mappa
- ·Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study
  
  Pagina :881-888
  
  R. Boyle, H.M. Klinger, Z. Shirzadi, G.T. Coughlan, M. Seto, M.J. Properzi, D.L. Townsend, Z. Yuan, C. Scanlon, R.J. Jutten, K.V. Papp, R.E. Amariglio, D.M. Rentz, J.P. Chhatwal, M.C. Donohue, R.A. Sperling, A.P. Schultz, Rachel F. Buckley, A4 Study Team
  Riassunto Riassunto Mappa Mappa
- ·Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data
  
  Pagina :889-894
  
  Gustavo A. Jimenez-Maggiora, A.P. Schulz, M.C. Donohue, H. Qiu, S.N. Jaiswal, O. Adegoke, R. Gallardo, O. Baryshnikava, R.A. Rissman, S. Abdel-Latif, R.A. Sperling, P.S. Aisen, A4 and LEARN Study Teams
  Riassunto Riassunto Mappa Mappa
Editorial
- ·On the 2024 Alzheimer’s Association Criteria: Still Not Ready for Clinical Use
  
  Pagina :895-896
  
  Robin Ziyue Zhou, A. Wimo, B. Winblad
  Mappa Mappa
Review
- ·Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer’s Disease. Are We Ready for the New Era?
  
  Pagina :897-902
  
  Roxanna Korologou-Linden, J. Kalsi, D. Kafetsouli, A. Olawale, D. Wingfield, D. Mummery, B. Hayhoe, O. Robinson, A. Majeed, L.T. Middleton
  Riassunto Riassunto Mappa Mappa
Brief Communication
- ·Examining the Diagnostic Accuracy of a Novel Performance-Based Test for Alzheimer’s Disease Screening
  
  Pagina :903-907
  
  A.M. Reed, K. Duff, L.E. Dibble, S.S. Paul, A. Hooyman, Sydney Y. Schaefer
  Riassunto Riassunto Mappa Mappa
Original Research
- ·Predicting Cognitive Decline for Non-Demented Adults with High Burden of Tau Pathology, Independent of Amyloid Status
  
  Pagina :908-916
  
  H.-S. Wu, L. Li, Q.-Q. Sun, C.-C. Tan, L. Tan, Wei Xu, Alzheimer’s Disease Neuroimaging Initiative
  Riassunto Riassunto Mappa Mappa
- ·Non-Genetic Risk Factors of Alzheimer’s Disease: An Updated Umbrella Review
  
  Pagina :917-927
  
  S.-Y. He, W.-M. Su, X.-J. Wen, S.-J. Lu, B. Cao, Bo Yan, Yong-Ping Chen
  Riassunto Riassunto Mappa Mappa
- ·Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
  
  Pagina :928-942
  
  Sandar Aye, R. Handels, B. Winblad, L. Jönsson
  Riassunto Riassunto Mappa Mappa
- ·Predicting Brain Amyloid Status Using the National Institute of Health Toolbox (NIHTB) for Assessment of Neurological and Behavioral Function
  
  Pagina :943-957
  
  Y. Cheng, E. Ho, S. Weintraub, D. Rentz, R. Gershon, Sudeshna Das, Hiroko H. Dodge
  Riassunto Riassunto Mappa Mappa
- ·Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment
  
  Pagina :958-965
  
  Y. Wang, D. Ren, J.S. Roberts, L.K. Tamres, J.H. Lingler
  Riassunto Riassunto Mappa Mappa
- ·Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment
  
  Pagina :966-974
  
  K.J. Mimmack, E.H. Sprague, R.E. Amariglio, P. Vannini, Gad A. Marshall, for the Alzheimer’s Disease Neuroimaging Initiative
  Riassunto Riassunto Mappa Mappa
Review
- ·Safety, Efficacy and Clinical Applications of Focused Ultrasound-Mediated Blood Brain Barrier Opening in Alzheimer’s Disease: A Systematic Review
  
  Pagina :975-982
  
  A. Patwardhan, T. Wilkinson, Y. Meng, I. Alhashyan, S.E. Black, N. Lipsman, Mario Masellis
  Riassunto Riassunto Mappa Mappa
Original Research
- ·Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States
  
  Pagina :983-991
  
  Feride H. Frech, G. Li, T. Juday, Y. Ding, S. Mattke, A. Khachaturian, A.S. Rosenberg, C. Ndiba-Markey, A. Rava, R. Batrla, S. De Santi, H. Hampel
  Riassunto Riassunto Mappa Mappa
Brief Communication
- ·Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of “Time Saved”
  
  Pagina :992-997
  
  Samuel P. Dickson, A. Solomon, M. Kivipelto, T. Hartmann, A M.J. van Hees, A. Brownlee, B. Haaland, C.H. Mallinckrodt, S.B. Hendrix
  Riassunto Riassunto Mappa Mappa
Review
- ·Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis
  
  Pagina :998-1012
  
  F.O. de Andrade Santos, A.A. Passos, Ricardo Mario Arida, L. Teixeira-Machado
  Riassunto Riassunto Mappa Mappa
Original Research
- ·Global Burden of Dementia Death from 1990 to 2019, with Projections to 2050: An Analysis of 2019 Global Burden of Disease Study
  
  Pagina :1013-1021
  
  Z. Li, N. Yang, L. He, J. Wang, Y. Yang, F. Ping, L. Xu, Huabing Zhang, Wei Li, Yuxiu Li
  Riassunto Riassunto Mappa Mappa
- ·Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels
  
  Pagina :1022-1029
  
  Soeren Mattke, Z. Shi, M. Hanson, S. Mitchell, C. Lynch, K. MacLean Kalonji, L. Lanman
  Riassunto Riassunto Mappa Mappa
- ·“Back to Braak”: Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer’s Disease Progression
  
  Pagina :1030-1040
  
  S. Censi, C. Sestieri, M. Punzi, A. Delli Pizzi, A. Ferretti, F. Gambi, V. Tomassini, Stefano Delli Pizzi, Stefano L. Sensi, Alzheimer’s Disease Neuroimaging Initiative
  Riassunto Riassunto Mappa Mappa
- ·Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-β42 over Amyloid Positron Emission Tomography
  
  Pagina :1041-1046
  
  J.-M. Pyun, M.J. Kang, S.J. Baek, K. Lee, Y.H. Park, SangYun Kim, Alzheimer’s Disease Neuroimaging Initiative
  Riassunto Riassunto Mappa Mappa
Review
- ·Association between Comorbidity Indices and Functional Autonomy in Individuals with Cognitive Impairment: A Systematic Review
  
  Pagina :1047-1054
  
  M.N. Temedda, A. Garnier-Crussard, C. Mouchoux, Virginie Dauphinot
  Riassunto Riassunto Mappa Mappa
Original Research
- ·Prediction of Alzheimer’s Disease Based on 3D Genome Selected circRNA
  
  Pagina :1055-1062
  
  R. Chi, K. Li, K. Su, L. Liu, M. Feng, X. Zhang, J. Wang, X. Li, Guang He, Yi Shi
  Riassunto Riassunto Mappa Mappa
- ·Female Reproductive Factors and Risk of Mild Cognitive Impairment and Dementia: The HUNT Study
  
  Pagina :1063-1072
  
  Yehani Wedatilake, C. Myrstad, S.E. Tom, B.H. Strand, S. Bergh, G. Selbæk
  Riassunto Riassunto Mappa Mappa
Brief Communication
- ·Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects
  
  Pagina :1073-1078
  
  G.M. Giuffrè, Davide Quaranta, M.G. Vita, E.M. Costantini, S. Citro, C. Carrozza, G. De Ninno, P. Calabresi, C. Marra
  Riassunto Riassunto Mappa Mappa
Original Research
- ·Interest in and Experience with Genetic Testing for Late-Onset Medical Conditions: Results from the National Poll on Healthy Aging
  
  Pagina :1079-1086
  
  S.J. Feldman, D. Blasco, M. Mones, J. Scott Roberts
  Riassunto Riassunto Mappa Mappa
- ·Association between Cerebrospinal Fluid sTREM2 Levels and Depression: The Alzheimer’s Disease Neuroimaging Initiative Study
  
  Pagina :1087-1092
  
  Y. Wang, M. Ye, Q. Ji, Q. Liu, Xiaowei Xu, Yiqiang Zhan
  Riassunto Riassunto Mappa Mappa
- ·Biomarkers and Cognition Study, Singapore (BIOCIS): Protocol, Study Design, and Preliminary Findings
  
  Pagina :1093-1105
  
  Y.J. Leow, J.D.J. Wang, A. Vipin, G.K. Sandhu, S.A. Soo, D. Kumar, A.A. Mohammed, F.Z.B. Zailan, F.P.H.E. Lee, S. Ghildiyal, S.Y. Liew, C. Dang, P. Tanoto, I.Y.Z. Tan, W.F.W. Chong, Nagaendran Kandiah
  Riassunto Riassunto Mappa Mappa
- ·Alzheimer’s Disease Prediction Using Fly-Optimized Densely Connected Convolution Neural Networks Based on MRI Images
  
  Pagina :1106-1121
  
  R. Sampath, M. Baskar
  Riassunto Riassunto Mappa Mappa
- ·The Insulin Sensitizer KBP-336 Prevents Diabetes-Induced Cognitive decline in ZDF Rats
  
  Pagina :1122-1131
  
  Anna Thorsø Larsen, K.E. Mohamed, E.A. Petersen, M.A. Karsdal, K. Henriksen
  Riassunto Riassunto Mappa Mappa
- ·Sex Difference in the Association between Prior Fracture and Subsequent Risk of Incident Dementia: A Longitudinal Cohort Study
  
  Pagina :1132-1139
  
  D. Gao, W. Rong, C. Li, J. Liang, Y. Wang, Y. Pan, W. Zhang, Fanfan Zheng, Wuxiang Xie
  Riassunto Riassunto Mappa Mappa
- ·Association between Resting Heart Rate and Machine Learning-Based Brain Age in Middle- and Older-Age
  
  Pagina :1140-1147
  
  J. Wang, H. Huang, W. Yang, A. Dove, Xiangyu Ma, Weili Xu
  Riassunto Riassunto Mappa Mappa
Review
- ·Periodontal Disease and Alzheimer’s: Insights from a Systematic Literature Network Analysis
  
  Pagina :1148-1165
  
  Alice Villar, S. Paladini, J. Cossatis
  Riassunto Riassunto Mappa Mappa
Original Research
- ·The Shape Trail Test Is Sensitive in Differentiating Older Adults with Mild Cognitive Impairment: A Culture-neutral Five-minute Test
  
  Pagina :1166-1176
  
  Z. Ding, Agnes S. Chan
  Riassunto Riassunto Mappa Mappa
Letter to the Editor
- ·Hypnotics and Incident Dementia: A Risk Assessment
  
  Pagina :1177
  
  Tomoyuki Kawada
- ·Update to: Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
  
  Pagina :1178-1179
  
  C. Rubel, T. Chen, Gersham Dent

Il mio account

Creare un account

Aide & support

Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.

Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.